• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

1
  • by alexperjescuadmin
  • in General Medicine
  • — 9 Dec, 2007
Large Risk Reduction For Rivaroxaban In Blood Clot Prevention
AudioMedica News
Large Risk Reduction For Rivaroxaban In Blood Clot Prevention
Large Risk Reduction For Rivaroxaban In Blood Clot Prevention
00:00 /
RSS Feed
Share
Link
Embed
Bengt Eriksson
Bengt Eriksson

REFERENCE: Abstract 6, American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
BENGT ERIKSSON, Gothenburg University
In a large phase III trial of patients having a hip replacement, the oral anticoagulant rivaroxaban has shown significant benefit when compared to enoxaparin. Derek Thorne heard more from Bengt Eriksson of Gothenburg University.

[audio:https://www.audiomedica.com/podcasting/general_medicine/071208_bengt_eriksson.mp3]
Share

Tags: annual meetinganticoagulantsanticoagulationashbengt erikssonbloodblood clotclotenoxaparingothenburg universityhematologichip replacementpatientpodcastpodcastingpreventionrisktrial

You may also like...

  • Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer 21 Mar, 2008
  • Entecavir for Hepatitis B Linked to HIV Resistance Entecavir for Hepatitis B Linked to HIV Resistance 20 Sep, 2007
  • Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability 4 Jan, 2008
  • Rosiglitazone for Patients with Diabetes: Cardiovascular Outcomes Trial Findings Rosiglitazone for Patients with Diabetes: Cardiovascular Outcomes Trial Findings 15 Jul, 2007

1 Comment

  1. Mert says:
    May 12, 2008 at 9:53 pm

    I am a medicine student in Turkey and I am hoping to have my specialty in Orthotics. I am really glad to listen such a nice podcast about current progresses in the field, I hope I can make similar research in the field as well.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
  • Next story No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with…
    • Radiotherapy Cuts BRCA-Associated Contralateral…
  • Home
  • General Medicine
  • Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.